US BROKER MOVES: CRM upgraded at BofA; ADBE downgraded at Wells Fargo

UPGRADES C3.ai (AI) Upgraded from Market Perform to Outperform at Northland; PT USD 16 Allison Transmission (ALSN) Upgraded from Neutral to Buy at Citi; PT USD 135 Allstate (ALL) Upgraded from Underweight to Equal Weight at Wells Fargo; PT USD 236 AST SpaceMobile (ASTS) Upgraded from Hold to Buy at Deutsche Bank; PT USD 93 Biogen (BIIB) Upgraded from Neutral to Overweight at JPMorgan; PT USD 300 BioMarin Pharmaceutical (BMRN) Upgraded from Outperform to Strong Buy at Raymond James; PT USD 109 Brown & Brown (BRO) Upgraded from Market Perform to Outperform at Keefe, Bruyette & Woods; PT USD 77 Blackstone Digital Infrastructure Trust (BXDC) Upgraded from Neutral to Buy at Citi; PT USD 20 Salesforce (CRM) Upgraded from Underperform to Buy at BofA Securities; PT USD 285 First Solar (FSLR) Upgraded from Hold to Buy at Truist Securities Hexcel (HXL) Upgraded from Neutral to Buy at Seaport Global Securities; PT USD 104 Humana (HUM) Upgraded from Market Perform to Outperform at Raymond James; PT USD 520 Manhattan Associates (MANH) Upgraded from Equalweight to Overweight at Morgan Stanley; PT USD 250 Mattel (MAT) Upgraded from Neutral to Buy at Seaport Global Securities SLM (SLM) Upgraded from Equalweight to Overweight at Morgan Stanley; PT USD 30 T-Mobile US (TMUS) Upgraded from Market Perform to Outperform at Raymond James; PT USD 170 Terreno Realty (TRNO) Upgraded from Market Perform to Outperform at BMO Capital; PT USD 75 Tyler Technologies (TYL) Upgraded from Equal Weight to Overweight at Wells Fargo; PT USD 400 DOWNGRADES Adobe (ADBE) Downgraded from Overweight to Underweight at Wells Fargo; PT USD 225 Enact Holdings (ACT) Downgraded from Neutral to Underweight at JPMorgan; PT USD 44 Alexandria Real Estate Equities (ARE) Downgraded from Market Perform to Underperform at BMO Capital; PT USD 41 Ally Financial (ALLY) Downgraded from Overweight to Equalweight at Morgan Stanley; PT USD 43 The Baldwin Insurance Group (BWIN) Downgraded from Buy to Hold at TD Cowen The Baldwin Insurance Group (BWIN) Downgraded from N/A to Market Perform at Keefe, Bruyette & Woods; PT USD 32.50 C.H. Robinson (CHRW) Downgraded from Buy to Hold at Deutsche Bank; PT USD 153 Freddie Mac (FMCC) Downgraded from Outperform to Neutral at Mizuho; PT USD 4 Fannie Mae (FNMA) Downgraded from Outperform to Neutral at Mizuho; PT USD 5 GoDaddy (GDDY) Downgraded from Outperform to Sector Perform at RBC Capital; PT USD 95 HubSpot (HUBS) Downgraded from Overweight to Equalweight at Barclays; PT USD 240 Insmed (INSM) Downgraded from Outperform to Peer Perform at Wolfe Research Monday.com (MNDY) Downgraded from Overweight to Equalweight at Barclays; PT USD 100 Microsoft (MSFT) Downgraded from Accumulate to Neutral at Phillip Securities; PT USD 515 Option Care Health (OPCH) Downgraded from Overweight to Equalweight at Morgan Stanley; PT USD 32.05 Palo Alto Networks (PANW) Downgraded from Buy to Neutral at Phillip Securities Palantir (PLTR) Downgraded from Buy to Neutral at Phillip Securities; PT USD 215 Roivant Sciences (ROIV) Downgraded from Outperform to Peer Perform at Wolfe Research Snowflake (SNOW) Downgraded from Buy to Accumulate at Phillip Securities; PT USD 423 UWM Holdings (UWMC) Downgraded from Buy to Neutral at BTIG INITIATIONS AbCellera Biologics (ABCL) Initiated at Buy at UBS; PT USD 18 AAmerican Bitcoin (ABTC) Initiated at Buy at H.C. Wainwright; PT USD 22 Amrize (AMRZ) Initiated at Buy at Longbow Research American Savings Bank, National Association (ASBH) Initiated at Buy at DA Davidson; PT USD 20 American Savings Bank, National Association (ASBH) Initiated at Market Perform at Keefe, Bruyette & Woods; PT USD 19 American Savings Bank, National Association (ASBH) Initiated at Overweight at Piper Sandler; PT USD 20 American Savings Bank, National Association (ASBH) Initiated at Overweight at Stephens; PT USD 21 Axogen (AXGN) Initiated at Buy at BofA Securities; PT USD 52 Beta Bionics (BBNX) Initiated at Buy at Jefferies; PT USD 30 Butterfly Network (BFLY) Initiated at Buy at Canaccord; PT USD 10 BioAge Labs (BIOA) Initiated at Neutral at UBS; PT USD 8 Brown & Brown (BRO) Initiated at Buy at TD Cowen Chemung Financial (CHMG) Initiated at Market Perform at Hovde Group Connect Biopharma (CNTB) Initiated at Outperform at Leerink; PT USD 4 Hemab Therapeutics Holdings (COAG) Initiated at Buy at Rodman & Renshaw; PT USD 56 Equillium (EQ) Initiated at Outperform at Leerink; PT USD 6 Evommune (EVMN) Initiated at Neutral at UBS; PT USD 8 Frontdoor (FTDR) Initiated at Neutral at Goldman Sachs; PT USD 81 Eva Live (GOAI) Initiated at Buy at Maxim Group; PT USD 7 Hartford Financial (HIG) Initiated at Hold at Truist Securities; PT USD 137 Robinhood (HOOD) Initiated at Outperform at Evercore ISI; PT USD 130 Interactive Brokers (IBKR) Initiated at Buy at Deutsche Bank; PT USD 102 Interactive Brokers (IBKR) Initiated at Outperform at Evercore ISI IDEXX Laboratories (IDXX) Initiated at Sector Weight at KeyBanc Kardigan (KARD) Initiated at Buy at UBS; PT USD 25 Las Vegas Sands (LVS) Initiated at Buy at Citi; PT USD 71.50 Melco Resorts & Entertainment (MLCO) Initiated at Buy at Citi; PT USD 9.40 Mineralys Therapeutics (MLYS) Initiated at Neutral at UBS; PT USD 29 Mind Medicine (MMED) Initiated at Hold at Jefferies; PT USD 22 Everspin Technologies (MRAM) Initiated at Buy at Maxim Group; PT USD 25 Nektar Therapeutics (NKTR) Initiated at Neutral at UBS; PT USD 53 Nektar Therapeutics (NKTR) Initiated at Outperform at Leerink; PT USD 130 Ocular Therapeutix (OCUL) Initiated at Buy at UBS; PT USD 14 Odyssey Therapeutics (ODTX) Initiated at Buy at UBS; PT USD 27 Prenetics Global (PRE) Initiated at Buy at Lucid Capital Markets; PT USD 54 Protagonist Therapeutics (PTGX) Initiated at Buy at UBS; PT USD 184 Quoin Pharmaceuticals (QNRX) Initiated at Buy at BTIG; PT USD 14 Q32 Bio (QTTB) Initiated at Outperform at Leerink; PT USD 40 Charles Schwab (SCHW) Initiated at In Line at Evercore ISI; PT USD 107 Shattuck Labs (STTK) Initiated at Buy at UBS; PT USD 17 Spyre Therapeutics (SYRE) Initiated at Buy at UBS; PT USD 120 Teck Resources (TECX) Initiated at Neutral at UBS; PT USD 26 First Financial (THFF) Initiated at Outperform at Hovde Group Vera Therapeutics (VERA) Initiated at Market Perform at Leerink; PT USD 34 Vylor (VYLR) Initiated at Buy at UBS; PT USD 89 TeraWulf (WULF) Initiated at Buy at TD Cowen; PT USD 21